Stories
-
Sebi orders to disgorge Rs 2.3 cr in insider trading case
Markets regulator Sebi on Monday asked Fourth Dimension Solutions Managing Director Amalendu Mukherjee to disgorge an amount worth over Rs…
Read More » -
Will proposing ‘TIBET CARD’ prevent development for the Indian Economy???
Recently a suggestion has been highlighted by some media outlets of India that after the deadly clashes erupted at the…
Read More » -
How Ramdev’s Ruchi Soya shares are hitting the top-list?
Ruchi Soya is one of the largest FMCG companies and major manufacturers of edible oil in India. They have been…
Read More » -
Infosys: More Than 200 Employees Stranded In US, Their Families Arrived In India By Chartered Plane By The Company.
Information technology, giant Infosys arranged to bring more than 200 of its employees and their families stranded in the US…
Read More » -
Government Has Changed The Rules Of PPF ; Customers Can Now Avail This Special Facility.
The government has taken a reprieve for the holders of Public Provident Fund (PPF) due to the lockdown. Those whose…
Read More » -
The Size Of The Economy Will Decrease By 9.13 Lakh Crores This Year.
The government has also said that due to Covid-19 and lockdown, there will be a serious impact on the economy…
Read More » -
If Police themself aren’t safe in India from gangsters like “Vikas Dubey” then How can a Common Man Feel safe?
Vikas Dubey is a notorious historical character in Uttar Pradesh. In other words, He is a punk, scoundrel, criminal, and…
Read More » -
Unemployment during COVID-19 – the most severe impact in this pandemic faced by individuals and economies!!
It is not hidden that how Covid-19 incapacitated the global job market and governments all over the globe. However, it…
Read More » -
India ranks 34th in JLL’s Global Realty Transparency Index
India’s Global Real Estate Transparency Index ranking has improved by one notch to 34 on the back of regulatory reforms,…
Read More » -
What would it mean for India if the coronavirus vaccine is invented right from us?
The Central Drugs Standard Control Organisation (CDSCO) has allowed Bharat Biotech India (BBIL) to conduct human clinical trials for ‘Covaxin’,…
Read More »